Comprehensive Characterization of the Immune Microenvironment Based on Nested Resampling Machine Learning Framework Identifies TRAF3 Interacting Protein 3 as a Promising Regulator to Improve the Resistance to Immunotherapy in Glioma
Advanced Science · 2025
DOI: 10.1002/advs.202502271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yanbo Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Drug Resistance, Neoplasm, Glioma, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Diffuse glioma, the most prevalent and malignant intracranial tumor, presents a formidable challenge due to its immunosuppressive microenvironment, which complicates conventional therapeutic approaches. This study conducted a comprehensive prognostic meta‐analysis involving 2,968 patients with diffuse glioma and established a comprehensive machine learning framework with nested resampling of 18 machine learning algorithms, and developed the Immune Glioma Survival Signature (IGLoS). This signature, comprising CCL19, ICOSLG, IL11, PTGES, TNFAIP3, and TRAF3IP3, has been demonstrated to predict survival outcomes across a range of cancers and to correlate with tumor progression at the level of multi‐omics. It is noteworthy that the IGLoS score enables precise patient stratification for personalized cancer treatments and elucidates pivotal resistance mechanisms to immunotherapy. Furthermore, siRNA screening has underscored the critical role of TRAF3IP3 in modulating PDL1 expression and immune pathways, with implications on the ERK pathway and NFATC2 involvement. Through single‐cell analysis of published and in‐house datasets, TRAF3IP3 exhibited selective enrichment in NPC‐like and MES‐like tumor cells, and showed a dual functionality in mediating T‐Cell Exhaustion. Targeting TRAF3IP3 emerges as a promising avenue to combat immunotherapy resistance, particularly in glioma, thus paving the way for precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
- Department of Neurosurgery, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100000, China.
- Department of Oncology, Division of Pediatric Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, 21231, US.
- Department of Neurosurgery, China-Japan Friendship Hospital, Beijing, 100000, China.
- Suzhou Medical College of Soochow University, Suzhou, Jiangsu, 215127, China.
- Department of Neurosurgery, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, 100000, China.
ORCID-Profile: Yanbo Yang, Zhouqing Chen
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
- National Key Research and Development Program of China
Zitieren
APA
Yang, Y., Wang, F., Zhang, Y., Huang, R., Zhang, C., Zhao, L., Dang, H., Tao, X., Lu, Y., Lu, D., Zhang, Y., He, K., Weng, J., Chen, Z., Wang, Z., & Yu, Y. (2025). Comprehensive Characterization of the Immune Microenvironment Based on Nested Resampling Machine Learning Framework Identifies TRAF3 Interacting Protein 3 as a Promising Regulator to Improve the Resistance to Immunotherapy in Glioma. Advanced Science. https://doi.org/10.1002/advs.202502271
Vancouver
Yang Y, Wang F, Zhang Y, Huang R, Zhang C, Zhao L, et al. Comprehensive Characterization of the Immune Microenvironment Based on Nested Resampling Machine Learning Framework Identifies TRAF3 Interacting Protein 3 as a Promising Regulator to Improve the Resistance to Immunotherapy in Glioma. Advanced Science. 2025. doi:10.1002/advs.202502271
BibTeX
@article{Yang2025,
author = {Yang, Yanbo and Wang, Fei and Zhang, Yulian and Huang, Run and Zhang, Chuanpeng and Zhao, Lu and Dang, Hanhan and Tao, Xinyu and Lu, Yue and Lu, Dengfeng and Zhang, Yunsheng and He, Kun and Weng, Jiancong and Chen, Zhouqing and Wang, Zhong and Yu, Yanbing},
title = {Comprehensive Characterization of the Immune Microenvironment Based on Nested Resampling Machine Learning Framework Identifies TRAF3 Interacting Protein 3 as a Promising Regulator to Improve the Resistance to Immunotherapy in Glioma},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202502271}
}
EUVIMED